Access the full text.
Sign up today, get DeepDyve free for 14 days.
Yanzhong Yang, M. Bedford (2012)
Protein arginine methyltransferases and cancerNature Reviews Cancer, 13
Maciej Pawlak, C. Scherer, Jin Chen, M. Roshon, H. Ruley (2000)
Arginine N-Methyltransferase 1 Is Required for Early Postimplantation Mouse Development, but Cells Deficient in the Enzyme Are ViableMolecular and Cellular Biology, 20
Xiaoxu Zhou, X. Zang, M. Ponnusamy, Monica Masucci, E. Tolbert, R. Gong, T. Zhao, Na Liu, G. Bayliss, L. Dworkin, S. Zhuang (2016)
Enhancer of Zeste Homolog 2 Inhibition Attenuates Renal Fibrosis by Maintaining Smad7 and Phosphatase and Tensin Homolog Expression.Journal of the American Society of Nephrology : JASN, 27 7
M. Venkatachalam, J. Weinberg, W. Kriz, A. Bidani (2015)
Failed Tubule Recovery, AKI-CKD Transition, and Kidney Disease Progression.Journal of the American Society of Nephrology : JASN, 26 8
Pinglong Xu, Xia Lin, Xin-Hua Feng (2016)
Posttranslational Regulation of Smads.Cold Spring Harbor perspectives in biology, 8 12
M. Elkouris, Haroula Kontaki, Athanasios Stavropoulos, A. Antonoglou, K. Nikolaou, M. Samiotaki, Eszter Szantai, Dimitra Saviolaki, P. Brown, P. Sideras, G. Panayotou, I. Talianidis (2016)
SET9-Mediated Regulation of TGF-β Signaling Links Protein Methylation to Pulmonary FibrosisCell Reports, 15
A. Sureshbabu, S. Muhsin, Mary Choi (2016)
TGF-β signaling in the kidney: profibrotic and protective effects.American journal of physiology. Renal physiology, 310 7
H. Lan, A. Chung (2012)
TGF-β/Smad signaling in kidney disease.Seminars in nephrology, 32 3
M. Grande, B. Sanchez-Laorden, Cristina López-Blau, Cristina, A. Frutos, A. Boutet, M. Arévalo, R. Rowe, Stephen, J. Weiss, J. López-Novoa, M. Nieto (2015)
Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established diseaseNature Medicine, 21
H. Iwasaki (2009)
Impaired PRMT1 activity in the liver and pancreas of type 2 diabetic Goto-Kakizaki rats.Life sciences, 85 3-4
S. Zhuang, Na Liu (2014)
EGFR signaling in renal fibrosisKidney International Supplements, 4
Frank Herrmann, F. Fackelmayer (2009)
Nucleo‐cytoplasmic shuttling of protein arginine methyltransferase 1 (PRMT1) requires enzymatic activityGenes to Cells, 14
Yihui Chen, Xun Xu, Minjie Sheng, Xiaoyan Zhang, Q. Gu, Zhi Zheng (2009)
PRMT-1 and DDAHs-induced ADMA upregulation is involved in ROS- and RAS-mediated diabetic retinopathy.Experimental eye research, 89 6
Qingzhu Sun, Li Liu, M. Roth, Jia Tian, Qirui He, Bo Zhong, Ruanjuan Bao, X. Lan, Congshan Jiang, Jian Sun, Xudong Yang, Shemin Lu (2015)
PRMT1 Upregulated by Epithelial Proinflammatory Cytokines Participates in COX2 Expression in Fibroblasts and Chronic Antigen-Induced Pulmonary InflammationThe Journal of Immunology, 195
Masako Inamitsu, S. Itoh, U. Hellman, P. Dijke, Mitsuyasu Kato (2006)
Methylation of Smad6 by protein arginine N‐methyltransferase 1FEBS Letters, 580
Xiao-ming Meng, D. Nikolic-Paterson, H. Lan (2016)
TGF-β: the master regulator of fibrosisNature Reviews Nephrology, 12
N. Tyagi, Kara Sedoris, M. Steed, A. Ovechkin, K. Moshal, S. Tyagi (2005)
Mechanisms of homocysteine-induced oxidative stress.American journal of physiology. Heart and circulatory physiology, 289 6
Yanyan Gao, Yaping Zhao, Juechao Zhang, Yang Lu, Xin Liu, Pengyu Geng, Baiqu Huang, Yu Zhang, Jun Lu (2016)
The dual function of PRMT1 in modulating epithelial-mesenchymal transition and cellular senescence in breast cancer cells through regulation of ZEB1Scientific Reports, 6
M. Pang, Jagan Kothapally, H. Mao, E. Tolbert, M. Ponnusamy, Y. Chin, S. Zhuang (2009)
Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy.American journal of physiology. Renal physiology, 297 4
B. Cha, Yaerin Park, B. Hwang, Soyoung Kim, E. Jho (2015)
Protein Arginine Methyltransferase 1 Methylates Smurf2Molecules and Cells, 38
V. Shuttleworth, L. Gaughan, L. Nawafa, Caitlin Mooney, S. Cobb, N. Sheerin, I. Logan (2018)
The methyltransferase SET9 regulates TGFB1 activation of renal fibroblasts via interaction with SMAD3Journal of Cell Science, 131
M. Grande, J. López-Novoa (2009)
Fibroblast activation and myofibroblast generation in obstructive nephropathyNature Reviews Nephrology, 5
Yoko Katsuno, J. Qin, J. Oses-Prieto, Hongjun Wang, O. Jackson-Weaver, Tingwei Zhang, Samy Lamouille, Jian Wu, A. Burlingame, Jian Xu, R. Derynck (2018)
Arginine methylation of SMAD7 by PRMT1 in TGF-β–induced epithelial–mesenchymal transition and epithelial stem-cell generationThe Journal of Biological Chemistry, 293
Jian Xu, A. Hongjun Wang, J. Oses-Prieto, Kalpana Makhijani, Yoko Katsuno, Ming Pei, Leilei Yan, Y. George Zheng, Alma Burlingame, Katja Brückner, R. Derynck (2013)
Arginine Methylation Initiates BMP-Induced Smad Signaling.Molecular cell, 51 1
G. Bouras, S. Deftereos, D. Tousoulis, G. Giannopoulos, G. Chatzis, D. Tsounis, M. Cleman, C. Stefanadis (2013)
Asymmetric Dimethylarginine (ADMA): a promising biomarker for cardiovascular disease?Current topics in medicinal chemistry, 13 2
Génesis Vega, Sebastián Alarcón, R. Martín (2016)
The cellular and signalling alterations conducted by TGF-β contributing to renal fibrosis.Cytokine, 88
J. Wysocka, C. Allis, S. Coonrod (2006)
Histone arginine methylation and its dynamic regulation.Frontiers in bioscience : a journal and virtual library, 11
Jun Wang, S. Zhuang (2017)
Src family kinases in chronic kidney disease.American journal of physiology. Renal physiology, 313 3
Juste Wesche, Sarah Kühn, B. Kessler, M. Salton, Alexander Wolf (2017)
Protein arginine methylation: a prominent modification and its demethylationCellular and Molecular Life Sciences, 74
Han-Song Wei, Rasika Mundade, Kevin Lange, T. Lu (2013)
Protein arginine methylation of non-histone proteins and its role in diseasesCell Cycle, 13
S. Avasarala, M. Scoyk, Manoj Rathinam, Sereke Zerayesus, Xiangmin Zhao, Wei Zhang, Melissa Pergande, J. Borgia, J. DeGregori, J. Port, R. Winn, R. Bikkavilli (2015)
PRMT1 Is a Novel Regulator of Epithelial-Mesenchymal-Transition in Non-small Cell Lung Cancer*The Journal of Biological Chemistry, 290
Dariusz Zakrzewicz, A. Zakrzewicz, K. Preissner, P. Markart, M. Wygrecka (2012)
Protein Arginine Methyltransferases (PRMTs): Promising Targets for the Treatment of Pulmonary DisordersInternational Journal of Molecular Sciences, 13
E. Schwedhelm, R. Böger (2011)
The role of asymmetric and symmetric dimethylarginines in renal diseaseNature Reviews Nephrology, 7
Dariusz Zakrzewicz, A. Zakrzewicz, M. Didiášová, Marek Korencak, D. Kosanovic, R. Schermuly, P. Markart, M. Wygrecka (2015)
Elevated protein arginine methyltransferase 1 expression regulates fibroblast motility in pulmonary fibrosis.Biochimica et biophysica acta, 1852 12
Yahui Tian, Fangfang Liao, Guoying Wu, Di Chang, Yaohui Yang, Xiaona Dong, Zhongwen Zhang, Yu Zhang, Guojuan Wu (2015)
Ubiquitination and regulation of Smad7 in the TGF-β1/Smad signaling of aristolochic acid nephropathyToxicology Mechanisms and Methods, 25
A. Loboda, Mateusz Sobczak, A. Józkowicz, J. Dulak (2016)
TGF-β1/Smads and miR-21 in Renal Fibrosis and InflammationMediators of Inflammation, 2016
Youhua Liu (2006)
Renal fibrosis: new insights into the pathogenesis and therapeutics.Kidney international, 69 2
Christopher Krause, Zhi-Hong Yang, Young-sun Kim, Jin-Hyung Lee, J. Cook, S. Pestka (2007)
Protein arginine methyltransferases: evolution and assessment of their pharmacological and therapeutic potential.Pharmacology & therapeutics, 113 1
Protein arginine methyltransferase 1 (PRMT1), which primarily causes asymmetric arginine methylation of histone and nonhistone proteins, has been found to activate gene expression and mediate multiple pathological processes. Its role in renal fibrosis, however, remains unclear. In the present study, we observed that PRMT1 and its specific epigenetic marker, asymmetric di-methylated histone 4 arginine 3 (H4R3Me2a), were highly expressed in cultured renal interstitial fibroblasts. Treatment of PRMT1 with AMI-1, a selective inhibitor of PRMT1, or silencing PRMT1 with siRNA inhibited serum-induced and transforming growth factor (TGF)-β1-induced expression of α-smooth muscle actin (α-SMA) and collagen type I, two hallmarks of renal fibroblast activation, in a dose-dependent and time-dependent manner. In a murine model of renal fibrosis induced by unilateral ureteral obstruction, PRMT1 expression and H4R3Me2a were also upregulated, which was coincident with increased expression of α-SMA, collagen type I, and fibronectin. Administration of AMI-1 reduced PRMT1 and H4R3Me2a expression, attenuated extracellular matrix protein deposition, and inhibited renal fibroblast activation and proliferation. Moreover, AMI-1 treatment inhibited Smad3 phosphorylation and TGF-β receptor I expression but prevented Smad7 downregulation both in the kidney after unilateral ureteral obstruction injury and in cultured renal interstitial fibroblasts exposed to TGF-β1. Collectively, these results demonstrate that PRMT1 may mediate renal fibroblast activation and renal fibrosis development through activation of the TGF-β/Smad3 signaling pathway. They also suggest that PRMT1 inhibition may be a potential therapeutic approach for the treatment of fibrotic kidney disease.
American Journal of Physiology-Renal Physiology – The American Physiological Society
Published: Feb 1, 2020
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.